We report mutations in infl uenza A virus (H5N1) strains associated with 2 outbreaks in Turkey. Four novel amino acid changes (Q447L, N556K, and R46K in RNA polymerase and S133A in hemagglutinin) were detected in virus isolates from 2 siblings who died. I nfl uenza A virus (H5N1) is the predominant candidate for a future infl uenza pandemic if it develops effi cient ability for human-to-human transmission. Since 2003, a total of 109 human deaths have been associated with this strain (1). Monitoring the genetic structure of this virus is needed for predicting changes that may confer ability to cause pandemics: pathogenicity, host range, and antigenic drift.
I nfl uenza A virus (H5N1) is the predominant candidate for a future infl uenza pandemic if it develops effi cient ability for human-to-human transmission. Since 2003, a total of 109 human deaths have been associated with this strain (1) . Monitoring the genetic structure of this virus is needed for predicting changes that may confer ability to cause pandemics: pathogenicity, host range, and antigenic drift.
Recently, 2 avian infl uenza A (H5N1) outbreaks occurred in Turkey. The fi rst outbreak, in Balikesir in northwestern Turkey in October 2005, was limited to poultry. The second outbreak, in Dogubeyazit in northeastern Turkey in November 2005, involved poultry and humans. As of January 2006, a total of 12 human cases, 4 fatal, have been confi rmed (1).
The Study
We analyzed molecular evolution of the virus genome by sequencing the hemagglutinin (HA), RNA polymerase (PB2), and matrix 2 (M2) genomic segments of 4 chicken and 2 human viral isolates. During the fi rst outbreak, the MYS viral isolate was obtained from a chicken. During the second outbreak, viral isolates SU, 13, and 20 were obtained from chickens in southeastern Turkey, Anatolia, and Istanbul, respectively. Human viral isolates FK and MAK were obtained from 2 siblings who died shortly after the second outbreak. Changes in the viral genomes are summarized in the Table. Amino acids at positions 16, 13, 18, 20, 28, 55, and 78 in M2 are associated with host specifi city; those at positions 31, 34, 26, 27, and 30 are associated with resistance to adamantanes (2) . All isolates in our study showed greatest homology to the M2 region of infl uenza A virus A/bar-headed goose/Qinghai /59/05 (H5N1) (GenBank accession no. AAZ16311). None of the isolates had amino acid changes associated with resistance to adamantanes. All chicken and human isolates from the second epidemic had a unique mutation (I42T) in the M2 region. Thus, the only difference between isolates from the 2 outbreaks is a mutation (T42) in isolates from the second outbreak.
The HA sequence of MYS showed 98% homology with that of infl uenza A virus A/chicken/Kurgan/3/2005 (H5N1) (GenBank accession no. DQ323672) and contained a unique mutation (S133A) near receptor binding residue GVSSAC at positions 134 through 139. HA cleavage sites of all isolates from Turkey contained the sequence PQGERRRKKRGLF, similar to that of infl uenza A virus A/duck/Novosibirsk/ 56/2005(H5N1) (accession no. ABB17275), which indicates their high virulence. MAK contained mutations D158N and S227N in the HA region. These 2 mutations are important because D158N results in a potential glycosylation site and S227N enhances affi nity for human receptors.
Enhanced pathogenic potential of all avian and human infl uenza virus isolates from the second outbreak was shown by mutation E627K in the PB2 region. In addition, unique amino acid changes found only in human isolates were Q447L in FK and Q447L, R46K, and N556K in MAK.
Conclusions
The Isolate  HA  PB2  M2  FK †  D158, S227  E627K, Q447L  I28V, I42T  MAK †  D158N, S227N  E627K, R46K,  Q447L, N556K   I28V, I42T   MYS ‡  D158, S133A,  S227   I28V   SU §  D158, S227  E627K  I28V, I42T  13 §  D158, S227  E627K  I28V, I42T  20 §  D158, S227  E627K  I28V, I42T *HA, hemagglutinin; PB2, RNA polymerase; M2, matrix 2 protein. †Human isolates from the second outbreak. ‡Chicken isolate from the first outbreak. §Chicken isolates from the second outbreak.
virus evolution in 1 patient. Human-to-human transmission and adaptation of the virus to infect humans have been suggested (3). Incomplete knowledge of the history of infections in humans and lack of sample availability limited our study. Unique mutations in PB2, particularly in these human isolates, emphasize the need for clinical, epidemiologic, and molecular studies for further understanding of the global pattern of evolution of infl uenza A virus (H5N1). The close location of mutation T42 to viral regions associated with host specifi city and resistance to adamantanes and isolation of virus with this mutation from humans should be studied. Although isolates from the FK and MAK group have not been available for comparison, the unique changes should be studied with respect to their ability to confer survival advantage to virus in humans.
